×
Hero Background
English
Chinese
French
Japanese
Korean
German
Spanish

Animal Model Market Trends

ID: MRFR/Pharma/8231-HCR
140 Pages
Rahul Gotadki
October 2025

Animal Model Market Research Report Information By Animal Type (Pigs, Cats, and Mice), By Technology (CRISPR, Microinjection, and Embryonic Stem Cell Injection), By Application (Research & Development, Production, and Quality Control), By End-User (Research Institutes, Educational Institutes, Pharmaceutical Companies, and Contract Research Organizations), And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) – Market Forecast Till 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Animal Model Market Infographic
Purchase Options

Market Trends

Introduction

As we take a look at the Animal Model Market in 2025, we see several macro-economic factors influencing its evolution. Gene therapy and biopharmaceuticals are enabling the development of more sophisticated and relevant animal models, which will lead to better research results. Meanwhile, regulatory pressures are intensifying, with the introduction of stricter ethical and animal-welfare guidelines, forcing the industry to adapt its practices. Also, a shift in consumer preferences towards a more sustainable and individualized approach to medicine is encouraging companies to focus their efforts on innovation. These macro-economic factors are vital for companies to understand, as they are not only shaping their competitive strategies, but also influencing the way they operate in the wider social and regulatory context.

Top Trends

  1. Increased Demand for Genetically Engineered Models
    The rise of precision medicine has brought a huge increase in demand for genetically engineered animal models, and companies like Horizon Discovery Group PLC are leading the way. By 2025, more than 60% of research institutions are expected to be using these models in drug development. These developments will improve the accuracy of preclinical studies, reducing the risk of late-stage clinical failures. The future will see the introduction of more complex gene-editing techniques, which will further increase the accuracy of these models.
  2. Regulatory Support for Animal Research
    The regulatory authorities are more and more aware of the importance of animal models in biomedical research and are easing their approval procedures. For example, the Food and Drug Administration (FDA) has issued guidelines that facilitate the use of animal models in drug testing. This is expected to lead to greater efficiency in research and faster drug development. As the regulatory framework evolves, compliance with the rules will become an increasingly important factor for the industry.
  3. Focus on Animal Welfare and Ethical Standards
    Animal welfare in research is becoming an increasingly important consideration, both in terms of public opinion and legislation. Higher ethical standards, such as those adopted by Charles River Laboratories, are becoming a source of competitive advantage. Surveys show that up to 75% of consumers prefer to buy products developed using humane methods. This trend may lead to higher costs, but it can also enhance brand loyalty and market reputation.
  4. Integration of AI and Machine Learning
    Artificial intelligence and machine learning are transforming data analysis and prediction in animal model research. Companies are using these methods to improve the accuracy of experimental results, with studies demonstrating a 30% increase in the success rate of predictions. This trend will help to speed up the development of new drugs and shorten the time to market. Advances in this area could even lead to the development of fully automated research environments.
  5. Expansion of Contract Research Organizations (CROs)
    The role of contract research organisations in the animal model market is growing. By offering specialised services, they are able to relieve the burden on pharmaceutical companies. It is estimated that by 2025, up to 40% of preclinical research will be outsourced to CROs like Envigo. This trend offers the advantages of cost savings and access to advanced technology, while allowing companies to focus on their core business. Competition and innovation in the sector are likely to increase as CROs continue to expand.
  6. Emergence of Personalized Animal Models
    Using the concept of personal medicine, a custom-made model of the patient’s disease is being developed. A company called Transposagen Biopharmaceuticals is an example of this. The aim of this development is to make preclinical research more relevant, which could lead to improved results in clinical trials. This development could also lead to more individualized treatment.
  7. Sustainability Initiatives in Animal Research
    The use of animal models is becoming a matter of great importance in the animal model industry, and the practice of companies is now aimed at reducing the impact on the environment. There are several initiatives to reduce waste and improve resource efficiency. It is both the regulatory pressure and the consumers' demands for sustainable development that have prompted this development. In the future, it may also be possible to use other animal models, which reduce the use of live animals even further.
  8. Globalization of Animal Model Research
    Research is becoming increasingly international. The globalization of scientific activities facilitates the exchange of animal models and data. The formation of international collaborations between companies is expected to increase the diversity of animal models available for research. This trend may lead to increased innovation and a better understanding of the pathophysiology of diseases. The future may also bring a greater use of standardized procedures that facilitate reproducibility.
  9. Advancements in Non-Invasive Techniques
    Non-intrusive methods of investigation, such as the use of non-destructive, non-stunning means of observation and recording, are revolutionizing the way in which animal models are studied. Several companies have developed methods for obtaining more accurate data by means of a greater ability to follow up physiological changes. The accuracy of the results has been reported as increasing by 25 per cent. This development will undoubtedly improve the quality of research and reduce the need for invasive procedures. And future developments may lead to even more accurate recording.
  10. Rise of Companion Animal Models
    In the United States the use of pet animals in research has become more common, especially in the study of human diseases. In the case of dogs and cats, companies are looking for a variety of uses. Preliminary studies have yielded some encouraging results. This trend is expected to broaden the scope of research and increase the translational value of research findings. Future developments will probably include more comprehensive studies that validate the use of these models.

Conclusion: Navigating the Animal Model Market Landscape

In the year 2025, the Animal Model Market will become more fragmented. The monopoly will be shared by the traditional and the new players. The established companies will use their experience and established network, and the new entrants will focus on innovation and research methods, such as the use of artificial intelligence and automation to increase efficiency. The geographical trend is that the importance of ethics and environmentalism is increasingly prominent, and companies need to adjust their strategies accordingly. In order to adapt to the changing market, companies need to have the flexibility of their products and services. In order to achieve the leading position in the Animal Model Market, the companies should be able to respond quickly to the changes in regulations and market demands. The key to the future development of the Animal Model Market is the integration of advanced technology and sustainable development.

Author
Rahul Gotadki
Assistant Manager

He holds an experience of about 7+ years in Market Research and Business Consulting, working under the spectrum of Life Sciences and Healthcare domains. Rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. His expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. In addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives

Leave a Comment

FAQs

What is the projected growth of the Animal Model market?

The Animal Model market is the expected increase in total market value of 5.92 USD billion over a defined forecast period 2025–2035. It is driven by factors such as demand trends, technological advances, regulatory changes, and geographic expansion.

What is the size of the Animal Model market?

Animal Model market size was valued at approximately 2.78 billion USD in 2024. This figure will reach 5.92 billion USD covering all regions (America, Europe, Asia, MEA and ROW), focusing its segments / services / distribution channels till 2035.

What is the CAGR of the Animal Model market?

Animal Model market is expected to grow at a CAGR of 7.12% between 2025 and 2035.

How much will the Animal Model market be worth by 2035?

Animal Model market is expected to be worth of 5.92 billion USD, reflecting growth driven by usage, technology and global demands by the end of 2035.

How will the Animal Model market perform over the next 10 years?

Over the next 10 years the Animal Model market is expected to shift from usd billion 2.78 to 5.92 billion USD, led by adoption of advanced tech, demographic trends, regulatory approvals, with potential headwinds from 2025 to 2035.

Which region held the largest market share in the animal model market?

North America had the largest share in the market of animal models.

Market Summary

As per MRFR analysis, the Animal Model Market Size was estimated at 2777.94 USD Million in 2024. The Animal Model industry is projected to grow from 2975.74 USD Million in 2025 to 5919.84 USD Million by 2035, exhibiting a compound annual growth rate (CAGR) of 7.12 during the forecast period 2025 - 2035.

Key Market Trends & Highlights

The Animal Model Market is experiencing robust growth driven by technological advancements and increasing demand for personalized medicine.

  • Technological advancements in animal models are enhancing research capabilities and outcomes.
  • North America remains the largest market, while Asia-Pacific is emerging as the fastest-growing region.
  • The drug discovery segment dominates the market, whereas the toxicology testing segment is witnessing rapid growth.
  • Rising demand for personalized medicine and advancements in genetic engineering techniques are key drivers propelling market expansion.

Market Size & Forecast

2024 Market Size 2777.94 (USD Million)
2035 Market Size 5919.84 (USD Million)
CAGR (2025 - 2035) 7.12%
Largest Regional Market Share in 2024 North America

Major Players

<p>Charles River Laboratories (US), Envigo (US), Taconic Biosciences (US), Harlan Laboratories (US), Crown Bioscience (US), Janvier Labs (FR), The Jackson Laboratory (US), Wuxi AppTec (CN), Inotiv (US)</p>

Market Trends

The Animal Model Market is currently experiencing a dynamic evolution, driven by advancements in biotechnology and an increasing emphasis on ethical research practices. Researchers and pharmaceutical companies are increasingly relying on animal models to better understand complex biological systems and to develop new therapies. This reliance is further fueled by the growing demand for personalized medicine, which necessitates the use of more sophisticated and representative animal models. As a result, the market is witnessing a shift towards more innovative and humane approaches in the selection and use of animal models, aligning with regulatory requirements and public expectations. Moreover, the Animal Model Market is also influenced by the rising prevalence of chronic diseases and the need for effective treatment options. The integration of technology, such as genetic engineering and advanced imaging techniques, is enhancing the capabilities of animal models, allowing for more accurate predictions of human responses. This trend suggests a potential for increased collaboration between academia and industry, as both sectors seek to leverage animal models for drug discovery and development. Overall, the Animal Model Market appears poised for continued growth, driven by scientific innovation and a commitment to ethical research practices.

Technological Advancements in Animal Models

The Animal Model Market is witnessing a surge in technological innovations that enhance the capabilities of animal models. Techniques such as CRISPR gene editing and advanced imaging are enabling researchers to create more precise and relevant models. These advancements facilitate a deeper understanding of disease mechanisms and improve the predictability of therapeutic outcomes.

Ethical Considerations and Regulatory Compliance

There is a growing emphasis on ethical considerations within the Animal Model Market, as stakeholders strive to align with regulatory frameworks and public sentiment. This trend indicates a shift towards the adoption of alternative methods and the refinement of existing practices to ensure humane treatment of animals, thereby fostering greater transparency and accountability.

Collaboration Between Academia and Industry

The Animal Model Market is increasingly characterized by collaborative efforts between academic institutions and industry players. Such partnerships are likely to enhance the development of innovative animal models, streamline the drug discovery process, and ultimately lead to more effective therapeutic solutions. This trend suggests a potential for shared resources and knowledge, benefiting both sectors.

Animal Model Market Market Drivers

Emerging Markets and Globalization

Emerging markets are increasingly contributing to the Global Animal Model Market Industry as globalization facilitates collaboration and knowledge exchange. Countries in Asia-Pacific and Latin America are witnessing a rise in research activities, driven by both local and international investments. This trend is fostering the development of regional animal model facilities and research institutions, which are essential for advancing scientific knowledge. The expansion of these markets is expected to enhance the overall growth of the industry, as they adopt advanced animal models for research purposes. The globalization of research initiatives is likely to create new opportunities for market players.

Advancements in Genetic Engineering

Advancements in genetic engineering techniques, such as CRISPR and gene editing, are significantly influencing the Global Animal Model Market Industry. These technologies enable the creation of more precise and relevant animal models that closely mimic human diseases. This precision enhances the predictability of drug responses, thereby improving the efficiency of preclinical trials. As a result, researchers are increasingly adopting these advanced models, which are expected to drive market growth. The integration of genetically modified organisms into research protocols is likely to contribute to the overall expansion of the market, aligning with the projected growth trajectory leading to 2035.

Rising Demand for Biopharmaceuticals

The increasing demand for biopharmaceuticals is a primary driver of the Global Animal Model Market Industry. As the biopharmaceutical sector expands, the need for effective preclinical testing using animal models becomes crucial. In 2024, the market is valued at approximately 2.79 USD Billion, reflecting the industry's reliance on animal models for drug development and safety assessments. This trend is expected to continue, with projections indicating a market growth to 5.93 USD Billion by 2035. The compound annual growth rate (CAGR) of 7.11% from 2025 to 2035 underscores the importance of animal models in facilitating the development of innovative therapies.

Regulatory Support for Animal Research

Regulatory support for animal research plays a pivotal role in the Global Animal Model Market Industry. Governments and regulatory bodies are increasingly recognizing the necessity of animal models in the drug development process. This support manifests through guidelines that promote ethical research practices while ensuring the welfare of animals used in studies. Such frameworks facilitate the approval of new drugs and therapies, thereby fostering innovation. As the market evolves, the alignment of regulatory policies with scientific advancements is likely to enhance the credibility and acceptance of animal models, further driving market growth through 2035.

Increasing Investment in Research and Development

The surge in investment in research and development (R&D) across various sectors is a significant driver of the Global Animal Model Market Industry. Pharmaceutical and biotechnology companies are allocating substantial resources to R&D to discover new therapies and treatments. This trend is reflected in the growing number of preclinical studies utilizing animal models, which are essential for understanding disease mechanisms and testing drug efficacy. The anticipated growth of the market from 2.79 USD Billion in 2024 to 5.93 USD Billion by 2035 highlights the critical role of R&D investments in shaping the future landscape of animal model applications.

Market Segment Insights

By Application: Drug Discovery (Largest) vs. Toxicology Testing (Fastest-Growing)

<p>The Animal Model Market is segmented into five primary applications: Drug Discovery, Toxicology Testing, Genetic Research, Disease Modeling, and Regenerative Medicine. Among these, Drug Discovery holds the largest market share, driven by the continuous demand for novel therapeutics and the need for preclinical testing in drug development. Toxicology Testing follows closely, highlighting its importance in assessing drug safety and efficacy before human trials, capturing a significant portion of the market due to increasing regulatory requirements.</p>

<p>Drug Discovery (Dominant) vs. Toxicology Testing (Emerging)</p>

<p>Drug Discovery remains the dominant force within the Animal Model Market as it encompasses various therapeutic areas requiring preclinical studies, essentially facilitating the pipeline of pharmaceutical innovations. In contrast, Toxicology Testing is emerging as a crucial sector; it is rapidly gaining traction due to heightened awareness and regulatory focus on safety in drug development. The increasing incidence of drug-related adverse effects has necessitated the implementation of rigorous toxicological assessments using animal models, pointing towards its vital role in ensuring public health and compliance with medical standards.</p>

By Type of Animal Model: Mice (Largest) vs. Non-Human Primates (Fastest-Growing)

<p>The Animal Model Market is increasingly dominated by the use of Mice, which account for a significant share due to their low cost and genetic similarity to humans. Following Mice, Rats and Non-Human Primates contribute notable portions of market share, focusing on specific research areas such as neurobiology and drug development. Zebrafish and Guinea Pigs hold smaller shares, often being preferred for specialized studies and breeding practices.</p>

<p>Mice (Dominant) vs. Non-Human Primates (Emerging)</p>

<p>Mice are the dominant model in the Animal Model Market due to their extensive genetic and biological similarities with humans, as well as their ease of breeding and handling. They are extensively used in various research fields including cancer, genetics, and behavioral studies. Non-Human Primates, on the other hand, are emerging as a vital segment due to their closer anatomical and physiological matches to humans, particularly in neurological and drug testing studies. Their growing demand is driven by the need for more accurate models that can reflect human responses.</p>

By Research Area: Oncology (Largest) vs. Neurology (Fastest-Growing)

<p>The Animal Model Market exhibits a complex landscape with varied shares across distinct research areas. Oncology holds the largest market share, as it is pivotal for drug development and testing, reflecting the considerable investments in cancer research. Following closely, neurology is emerging as a significant sector due to increasing research initiatives targeted towards neurodegenerative diseases, driving its market share to expand rapidly. As the industry adapts to evolving healthcare needs, other areas like cardiology, immunology, and metabolic disorders also contribute to a diversified market share across the segment values.</p>

<p>Oncology (Dominant) vs. Neurology (Emerging)</p>

<p>Oncology remains the dominant research area in the Animal Model Market, driven by an increasing demand for effective cancer therapies and the sophisticated models that aid in understanding tumor biology. Researchers utilize various animal models to evaluate the efficacy and safety of new oncology drugs, which fosters innovation. In contrast, neurology, while currently in an emerging phase, is gaining traction due to heightened awareness of mental health issues and neurodegenerative conditions. This shift has encouraged investments in animal models that can accurately replicate neurological diseases, accelerating drug discovery and therapeutic interventions.</p>

By End User: Pharmaceutical Companies (Largest) vs. Biotechnology Firms (Fastest-Growing)

<p>The Animal Model Market is characterized by a diverse range of end users, with pharmaceutical companies holding the largest share. This segment benefits from the increasing need for drug development and testing in preclinical phases, driving substantial demand for animal models. Following closely are biotechnology firms, which are rapidly gaining traction as they leverage innovative techniques in drug discovery and therapeutic development. In recent years, biotechnology firms have emerged as the fastest-growing segment within the Animal Model Market. This growth is propelled by the rising investment in biopharmaceuticals and increased collaborations with academic institutions and contract research organizations. As advancements in genomics and personalized medicine continue to evolve, the reliance on animal models for validation and research purposes is expected to surge, contributing to further market growth across all end-user segments.</p>

<p>Pharmaceutical Companies (Dominant) vs. Contract Research Organizations (Emerging)</p>

<p>Pharmaceutical companies serve as the dominant players in the Animal Model Market, leveraging extensive resources for research and development purposes. They rely heavily on animal models for preclinical testing, allowing them to assess the efficacy and safety of new drugs before human trials. This demographic is deeply invested in advancing therapeutic options and demonstrates strong demand for a variety of animal models to support their diverse research needs. In contrast, contract research organizations (CROs) are emerging as pivotal partners, providing specialized expertise and services for pharmaceutical and biotechnology companies. Their ability to offer flexible solutions and keep pace with regulatory demands positions them as important contributors to the market’s growth, enhancing preclinical research capabilities and accelerating the drug development process.</p>

Get more detailed insights about Animal Model Market Research Report - Forecast till 2035

Regional Insights

North America : Market Leader in Animal Models

North America continues to lead The Animal Model, holding a significant share of 1390.0M in 2024. The region's growth is driven by robust investments in biomedical research, increasing demand for personalized medicine, and stringent regulatory frameworks that ensure high standards in animal welfare. The presence of advanced research facilities and a strong focus on innovation further catalyze market expansion. The United States is the primary contributor, housing key players like Charles River Laboratories and The Jackson Laboratory. The competitive landscape is characterized by a mix of established firms and emerging biotech companies, all striving to meet the growing demand for high-quality animal models. This dynamic environment fosters collaboration and innovation, positioning North America as a hub for animal model research and development.

Europe : Emerging Market with Growth Potential

Europe's Animal Model Market is valued at 800.0M, reflecting a growing interest in preclinical research and drug development. The region benefits from supportive regulatory frameworks and funding initiatives aimed at enhancing research capabilities. Increasing investments in biotechnology and pharmaceutical sectors are also driving demand for animal models, particularly in countries like Germany and France, which are at the forefront of research innovation. Germany, France, and the UK are leading countries in this market, hosting several key players such as Janvier Labs and Envigo. The competitive landscape is marked by collaborations between academic institutions and industry players, fostering advancements in animal model technologies. As the market evolves, Europe is poised to become a significant player in the global landscape, focusing on ethical research practices and innovative solutions.

Asia-Pacific : Rapidly Growing Research Hub

The Asia-Pacific region, with a market size of 470.0M, is rapidly emerging as a key player in the Animal Model Market. The growth is fueled by increasing investments in healthcare and biotechnology, coupled with a rising demand for innovative therapies. Countries like China and Japan are leading this trend, supported by government initiatives aimed at enhancing research infrastructure and capabilities in life sciences. China is particularly noteworthy, with a burgeoning biotech sector and a growing number of research institutions. The competitive landscape features both local and international players, including Wuxi AppTec, which is expanding its footprint in the region. As the demand for animal models continues to rise, Asia-Pacific is set to play a crucial role in global research and development efforts, focusing on both quality and ethical standards.

Middle East and Africa : Emerging Market with Unique Challenges

The Middle East and Africa region, valued at 117.94M, presents unique challenges and opportunities in the Animal Model Market. The growth is driven by increasing investments in healthcare and research, although regulatory hurdles and ethical considerations remain significant barriers. Countries like South Africa and the UAE are making strides in establishing research facilities and fostering collaborations to enhance their capabilities in animal model research. South Africa is leading the way, with a focus on improving research standards and ethical practices. The competitive landscape is still developing, with a mix of local and international players. As the region continues to invest in research and development, it is expected to gradually overcome existing challenges, paving the way for a more robust animal model market.

Key Players and Competitive Insights

The Animal Model Market is currently characterized by a dynamic competitive landscape, driven by increasing demand for innovative research methodologies and the growing prevalence of chronic diseases. Key players such as Charles River Laboratories (US), Envigo (US), and The Jackson Laboratory (US) are strategically positioned to leverage their extensive portfolios and expertise in preclinical research. Charles River Laboratories (US) focuses on enhancing its service offerings through technological advancements and strategic partnerships, which appear to bolster its market presence. Meanwhile, Envigo (US) emphasizes sustainability and ethical practices in animal research, aligning its operations with evolving regulatory standards and consumer expectations. The collective strategies of these companies contribute to a moderately fragmented market structure, where innovation and operational efficiency are paramount for competitive differentiation.

In terms of business tactics, companies are increasingly localizing manufacturing and optimizing supply chains to enhance responsiveness to market demands. This approach not only reduces lead times but also mitigates risks associated with global supply chain disruptions. The competitive structure of the market remains moderately fragmented, with several players vying for market share. The influence of key players is significant, as their strategic initiatives often set industry benchmarks and drive overall market growth.

In November 2025, Charles River Laboratories (US) announced a strategic partnership with a leading biotechnology firm to develop advanced gene-editing models. This collaboration is poised to enhance their research capabilities, particularly in the field of personalized medicine, thereby positioning Charles River as a frontrunner in innovative animal model solutions. The strategic importance of this partnership lies in its potential to accelerate the development of novel therapies, which could significantly impact patient outcomes.

In October 2025, The Jackson Laboratory (US) launched a new line of genetically engineered mouse models aimed at facilitating cancer research. This initiative reflects the company's commitment to addressing critical research needs and underscores its role as a key player in the oncology research space. The introduction of these models is likely to attract a diverse clientele, further solidifying The Jackson Laboratory's market position.

In September 2025, Envigo (US) expanded its facilities in Europe to enhance its capacity for breeding and supplying laboratory animals. This expansion is strategically important as it not only increases production capabilities but also aligns with the growing demand for high-quality animal models in the European market. Such moves are indicative of Envigo's proactive approach to scaling operations in response to market trends.

As of December 2025, the Animal Model Market is witnessing a shift towards digitalization, sustainability, and the integration of artificial intelligence in research methodologies. Strategic alliances among key players are increasingly shaping the competitive landscape, fostering innovation and collaboration. The evolution of competitive differentiation appears to be moving away from price-based competition towards a focus on technological advancements, reliability in supply chains, and the ethical treatment of research animals. This trend suggests that companies that prioritize innovation and sustainability will likely emerge as leaders in the market.

Key Companies in the Animal Model Market market include

Industry Developments

  • Q2 2024: Charles River Laboratories Announces Opening of New Preclinical Research Facility in North Carolina Charles River Laboratories opened a new state-of-the-art preclinical research facility in North Carolina to expand its capacity for animal model-based drug development and testing.
  • Q1 2024: GenOway and Merck KGaA Announce Strategic Partnership to Develop Next-Generation Humanized Mouse Models GenOway entered a strategic partnership with Merck KGaA to co-develop advanced humanized mouse models for immuno-oncology and autoimmune disease research.
  • Q2 2024: Taconic Biosciences Launches New CRISPR-Engineered Rat Model for Neurological Disease Research Taconic Biosciences launched a new CRISPR-engineered rat model designed to accelerate preclinical studies in neurological disorders.
  • Q3 2024: Eurofins Scientific Expands Animal Model Market Services with Acquisition of Preclinical CRO in Japan Eurofins Scientific acquired a leading Japanese preclinical contract research organization to strengthen its animal model services and global reach.
  • Q2 2024: The Jackson Laboratory Receives NIH Grant to Develop Rare Disease Mouse Models The Jackson Laboratory was awarded a multi-million dollar NIH grant to develop and distribute new mouse models for rare genetic diseases.
  • Q1 2025: Envigo Appoints New CEO to Lead Global Expansion in Animal Model Market Research Envigo announced the appointment of a new CEO to drive its global expansion and innovation in animal model research services.
  • Q2 2025: Charles River Laboratories Acquires Hera BioLabs to Expand Portfolio of Gene-Edited Animal Models Charles River Laboratories acquired Hera BioLabs, enhancing its portfolio of gene-edited animal models for drug discovery and safety testing.
  • Q1 2024: Biocytogen Raises $60 Million in Series C Funding to Accelerate Development of Humanized Animal Models Biocytogen secured $60 million in Series C funding to expand its pipeline of humanized animal models for pharmaceutical research.
  • Q3 2024: JSR Corporation Announces Strategic Investment in Ozgene to Advance Genetically Modified Animal Model Market Technologies JSR Corporation made a strategic investment in Ozgene to support the development of next-generation genetically modified animal models.
  • Q2 2025: PerkinElmer Launches New Zebrafish Model Platform for High-Throughput Drug Screening PerkinElmer introduced a new zebrafish model platform aimed at enabling high-throughput drug screening for early-stage pharmaceutical research.
  • Q1 2025: Trans Genic Inc. Wins Major Contract to Supply Custom Animal Models for European Biotech Consortium Trans Genic Inc. secured a significant contract to supply custom animal models to a consortium of European biotech firms for collaborative research projects.
  • Q2 2024: Envigo Opens New Animal Model Market Production Facility in Germany Envigo opened a new production facility in Germany to meet growing demand for specialized animal models in European biomedical research.

Future Outlook

Animal Model Market Future Outlook

<p>The Animal Model Market is projected to grow at a 7.12% CAGR from 2024 to 2035, driven by advancements in biotechnology, increasing R&D investments, and regulatory support.</p>

New opportunities lie in:

  • <p>Development of genetically modified animal models for precision medicine</p>
  • <p>Expansion of contract research organizations offering animal model services</p>
  • <p>Integration of AI technologies for enhanced data analysis in animal studies</p>

<p>By 2035, the Animal Model Market is expected to be robust, driven by innovation and strategic partnerships.</p>

Market Segmentation

Animal Model Market End User Outlook

  • Pharmaceutical Companies
  • Biotechnology Firms
  • Academic Institutions
  • Contract Research Organizations
  • Government Research Laboratories

Animal Model Market Application Outlook

  • Drug Discovery
  • Toxicology Testing
  • Genetic Research
  • Disease Modeling
  • Regenerative Medicine

Animal Model Market Research Area Outlook

  • Oncology
  • Neurology
  • Cardiology
  • Immunology
  • Metabolic Disorders

Animal Model Market Type of Animal Model Outlook

  • Mice
  • Rats
  • Non-Human Primates
  • Zebrafish
  • Guinea Pigs

Report Scope

MARKET SIZE 20242777.94(USD Million)
MARKET SIZE 20252975.74(USD Million)
MARKET SIZE 20355919.84(USD Million)
COMPOUND ANNUAL GROWTH RATE (CAGR)7.12% (2024 - 2035)
REPORT COVERAGERevenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR2024
Market Forecast Period2025 - 2035
Historical Data2019 - 2024
Market Forecast UnitsUSD Million
Key Companies ProfiledCharles River Laboratories (US), Envigo (US), Taconic Biosciences (US), Harlan Laboratories (US), Crown Bioscience (US), Janvier Labs (FR), The Jackson Laboratory (US), Wuxi AppTec (CN), Inotiv (US)
Segments CoveredApplication, Type of Animal Model, Research Area, End User
Key Market OpportunitiesAdvancements in genetic engineering enhance precision in the Animal Model Market for drug development.
Key Market DynamicsRising demand for advanced therapies drives innovation and competition in the Animal Model Market.
Countries CoveredNorth America, Europe, APAC, South America, MEA

FAQs

What is the projected growth of the Animal Model market?

The Animal Model market is the expected increase in total market value of 5.92 USD billion over a defined forecast period 2025–2035. It is driven by factors such as demand trends, technological advances, regulatory changes, and geographic expansion.

What is the size of the Animal Model market?

Animal Model market size was valued at approximately 2.78 billion USD in 2024. This figure will reach 5.92 billion USD covering all regions (America, Europe, Asia, MEA and ROW), focusing its segments / services / distribution channels till 2035.

What is the CAGR of the Animal Model market?

Animal Model market is expected to grow at a CAGR of 7.12% between 2025 and 2035.

How much will the Animal Model market be worth by 2035?

Animal Model market is expected to be worth of 5.92 billion USD, reflecting growth driven by usage, technology and global demands by the end of 2035.

How will the Animal Model market perform over the next 10 years?

Over the next 10 years the Animal Model market is expected to shift from usd billion 2.78 to 5.92 billion USD, led by adoption of advanced tech, demographic trends, regulatory approvals, with potential headwinds from 2025 to 2035.

Which region held the largest market share in the animal model market?

North America had the largest share in the market of animal models.

  1. EXECUTIVE SUMMARY
    1. Market Attractiveness Analysis
      1. Global Animal Model Market, by Animal Type
      2. Global Animal Model Market, by Technique
      3. Global Animal Model Market, by Application
      4. Global Animal Model Market, by End User
  2. MARKET INTRODUCTION
    1. Definition
    2. Scope of the Study
      1. Research Objective
      2. Assumptions
      3. Limitations
  3. RESEARCH METHODOLOGY
    1. Overview
    2. Data Mining
    3. Secondary Research
    4. Primary Research
      1. Breakdown of Primary Respondents
    5. Forecasting Techniques
    6. Research Methodology for Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
    7. Data Triangulation
    8. Validation
  4. MARKET DYNAMICS
    1. Overview
    2. Drivers
    3. Restraints
    4. Opportunities
  5. MARKET FACTOR ANALYSIS
    1. Porter’s Five Forces Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of New Entrants
      4. Threat of Substitutes
      5. Intensity of Rivalry
    2. Value Chain Analysis
      1. R&D and Designing
      2. Manufacturing
      3. Distribution & Sales
      4. Post Sales Services
    3. Impact of COVID 19 on Animal Model Market
      1. Impact on Market Value in 2020 and 2021
      2. Clinical Trial Impact
      3. Strategies to Overcome the challenges
      4. Impact on Supply Chain
      5. Impact on Pricing
  6. GLOBAL ANIMAL MODEL MARKET, BY ANIMAL TYPE
    1. Overview
    2. Mice
  7. Market Estimates & Forecast, by Region, 2020–2027
  8. Market Estimates & Forecast, by Country, 2020–2027
    1. Rats
  9. Market Estimates & Forecast, by Region, 2020–2027
  10. Market Estimates & Forecast, by Country, 2020–2027
    1. Pigs
  11. Market Estimates & Forecast, by Region, 2020–2027
  12. Market Estimates & Forecast, by Country, 2020–2027
    1. Rabbits
  13. Market Estimates & Forecast, by Region, 2020–2027
  14. Market Estimates & Forecast, by Country, 2020–2027
    1. Others
  15. Market Estimates & Forecast, by Region, 2020–2027
  16. Market Estimates & Forecast, by Country, 2020–2027
  17. GLOBAL ANIMAL MODEL MARKET, BY TECHNIQUE
    1. Overview
    2. CRISPR
  18. Market Estimates & Forecast, by Region, 2020–2027
  19. Market Estimates & Forecast, by Country, 2020–2027
  20. Microinjection
  21. Market Estimates & Forecast, by Region, 2020–2027
  22. Market Estimates & Forecast, by Country, 2020–2027
  23. Electroporation
  24. Market Estimates & Forecast, by Region, 2020–2027
  25. Market Estimates & Forecast, by Country, 2020–2027
    1. Others
  26. Market Estimates & Forecast, by Region, 2020–2027
  27. Market Estimates & Forecast, by Country, 2020–2027
  28. GLOBAL ANIMAL MODEL MARKET, BY APPLICATION
    1. Overview
    2. Research and Development
  29. Market Estimates & Forecast, by Region, 2020–2027
  30. Market Estimates & Forecast, by Country, 2020–2027
  31. Cardiovascular
  32. Market Estimates & Forecast, by Region, 2020–2027
  33. Market Estimates & Forecast, by Country, 2020–2027
  34. Infectious Diseases
  35. Market Estimates & Forecast, by Region, 2020–2027
  36. Market Estimates & Forecast, by Country, 2020–2027
  37. Metabolic Diseases
  38. Market Estimates & Forecast, by Region, 2020–2027
  39. Market Estimates & Forecast, by Country, 2020–2027
  40. Immunological Diseases
  41. Market Estimates & Forecast, by Region, 2020–2027
  42. Market Estimates & Forecast, by Country, 2020–2027
  43. Cancer
  44. Market Estimates & Forecast, by Region, 2020–2027
  45. Market Estimates & Forecast, by Country, 2020–2027
  46. Diabetes
  47. Market Estimates & Forecast, by Region, 2020–2027
  48. Market Estimates & Forecast, by Country, 2020–2027
  49. Genetic Diseases
  50. Market Estimates & Forecast, by Region, 2020–2027
  51. Market Estimates & Forecast, by Country, 2020–2027
  52. Neurological Diseases
  53. Market Estimates & Forecast, by Region, 2020–2027
  54. Market Estimates & Forecast, by Country, 2020–2027
  55. Others
  56. Market Estimates & Forecast, by Region, 2020–2027
  57. Market Estimates & Forecast, by Country, 2020–2027
    1. Production and Quality Control
  58. Market Estimates & Forecast, by Region, 2020–2027
  59. Market Estimates & Forecast, by Country, 2020–2027
  60. GLOBAL ANIMAL MODEL MARKET, BY END USER
    1. Overview
    2. Research Institutes
  61. Market Estimates & Forecast, by Region, 2020–2027
  62. Market Estimates & Forecast, by Country, 2020–2027
    1. Educational Institutes
  63. Market Estimates & Forecast, by Region, 2020–2027
  64. Market Estimates & Forecast, by Country, 2020–2027
    1. Pharmaceutical Companies
  65. Market Estimates & Forecast, by Region, 2020–2027
  66. Market Estimates & Forecast, by Country, 2020–2027
    1. Contract Research Organizations
  67. Market Estimates & Forecast, by Region, 2020–2027
  68. Market Estimates & Forecast, by Country, 2020–2027
  69. GLOBAL ANIMAL MODEL MARKET, BY REGION
    1. Overview
    2. Americas
      1. North America
      2. Latin America
    3. Europe
      1. Western Europe
      2. Eastern Europe
    4. Asia-Pacific
      1. Japan
      2. China
      3. India
      4. Australia
      5. South Korea
      6. Rest of Asia-Pacific
    5. Middle East & Africa
      1. Middle East
      2. Africa
  70. COMPANY LANDSCAPE
    1. Overview
    2. Competitor Dashboard
    3. Major Growth Strategy in the Global Animal Model Market
    4. Competitive Benchmarking
    5. The Leading Player in terms of Number of Developments in the Global Animal Model Market
    6. Key Developments & Growth Strategies
      1. New Product Launch/Service Deployment
      2. Merger & Acquisition
      3. Joint Ventures
    7. Major Players Financial Matrix & Market Ratio
      1. Sales & Operating Income 2019
      2. Major Players R&D Expenditure 2019
  71. COMPANY PROFILES
    1. Janvier Labs
      1. Company Overview
      2. Products/Services Offered
      3. Financial Overview
      4. Key Developments
      5. SWOT Analysis
      6. Key Strategies
    2. Charles River Laboratories
    3. GenOway S.A.
    4. Envigo
    5. Taconic Laboratories
    6. Transgenic, Inc.
    7. SAGE Labs
    8. Horizon Discovery
    9. Crown Bioscience Inc.
    10. Harbor Antibodies Bv (A Subsidiary of Harbor BioMed)
    11. Others
  72. APPENDIX
    1. References
    2. Related Reports
    3. NOTE:
    4. This table of content is tentative and subject to change as the research progresses.
    5.   In section 12, only the top companies will be profiled. Each company will be profiled based on the Market Overview, Financials, Product Portfolio, Business Strategies, and Recent Developments parameters.
    6.   Please note: The financial details of the company cannot be provided if the information is not available in the public domain and or from reliable sources.
  73. LIST OF TABLES
  74. GLOBAL ANIMAL MODEL MARKET SYNOPSIS, 2017–2027
  75. GLOBAL ANIMAL MODEL MARKET ESTIMATES & FORECAST, 2020–2027 (USD MILLION)
  76. GLOBAL ANIMAL MODEL MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION)
  77. GLOBAL ANIMAL MODEL MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
  78. GLOBAL ANIMAL MODEL MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
  79. GLOBAL ANIMAL MODEL MARKET, BY END USERS, 2020–2027 (USD MILLION)
  80. GLOBAL ANIMAL MODEL MARKET, BY REGION, 2020–2027 (USD MILLION)
  81. NORTH AMERICA: ANIMAL MODEL MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION)
  82. NORTH AMERICA: ANIMAL MODEL MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
  83. NORTH AMERICA: ANIMAL MODEL MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
  84. NORTH AMERICA: ANIMAL MODEL MARKET, BY END USERS, 2020–2027 (USD MILLION)
  85. US: ANIMAL MODEL MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION)
  86. US: ANIMAL MODEL MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
  87. US: ANIMAL MODEL MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
  88. US: ANIMAL MODEL MARKET, BY END USERS, 2020–2027 (USD MILLION)
  89. CANADA: ANIMAL MODEL MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION)
  90. CANADA: ANIMAL MODEL MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
  91. CANADA: ANIMAL MODEL MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
  92. CANADA: ANIMAL MODEL MARKET, BY END USERS, 2020–2027 (USD MILLION)
  93. LATIN AMERICA: ANIMAL MODEL MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION)
  94. LATIN AMERICA: ANIMAL MODEL MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
  95. LATIN AMERICA: ANIMAL MODEL MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
  96. LATIN AMERICA: ANIMAL MODEL MARKET, BY END USERS, 2020–2027 (USD MILLION)
  97. EUROPE: ANIMAL MODEL MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION)
  98. EUROPE: ANIMAL MODEL MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
  99. EUROPE: ANIMAL MODEL MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
  100. EUROPE: ANIMAL MODEL MARKET, BY END USERS, 2020–2027 (USD MILLION)
  101. WESTERN EUROPE: ANIMAL MODEL MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION)
  102. WESTERN EUROPE: ANIMAL MODEL MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
    1. TABLE 30
  103. WESTERN EUROPE: ANIMAL MODEL MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
  104. WESTERN EUROPE: ANIMAL MODEL MARKET, BY END USERS, 2020–2027 (USD MILLION)
  105. EASTERN EUROPE: ANIMAL MODEL MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION)
  106. EASTERN EUROPE: ANIMAL MODEL MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
  107. EASTERN EUROPE: ANIMAL MODEL MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
  108. EASTERN EUROPE: ANIMAL MODEL MARKET, BY END USERS, 2020–2027 (USD MILLION)
  109. ASIA-PACIFIC: ANIMAL MODEL MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION)
  110. ASIA-PACIFIC: ANIMAL MODEL MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
  111. ASIA-PACIFIC: ANIMAL MODEL MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
  112. ASIA-PACIFIC: ANIMAL MODEL MARKET, BY END USERS, 2020–2027 (USD MILLION)
  113. MIDDLE EAST & AFRICA: ANIMAL MODEL MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION)
  114. MIDDLE EAST & AFRICA: ANIMAL MODEL MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
  115. MIDDLE EAST & AFRICA: ANIMAL MODEL MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
  116. MIDDLE EAST & AFRICA: ANIMAL MODEL MARKET, BY END USERS, 2020–2027 (USD MILLION)
  117. LIST OF FIGURES
  118. RESEARCH PROCESS
  119. MARKET STRUCTURE FOR THE GLOBAL ANIMAL MODEL MARKET
  120. MARKET DYNAMICS FOR THE GLOBAL ANIMAL MODEL MARKET
  121. GLOBAL ANIMAL MODEL MARKET SHARE, BY ANIMAL TYPE, 2018 (%)
  122. GLOBAL ANIMAL MODEL MARKET SHARE, BY TECHNIQUE, 2018 (%)
  123. GLOBAL ANIMAL MODEL MARKET SHARE, BY APPLICATION 2018 (%)
  124. GLOBAL ANIMAL MODEL MARKET SHARE, BY END USERS, 2018 (%)
  125. GLOBAL ANIMAL MODEL MARKET SHARE, BY REGION, 2018 (%)
  126. AMERICAS: ANIMAL MODEL MARKET SHARE BY REGION, 2018 (%)
  127. NORTH AMERICA: ANIMAL MODEL MARKET SHARE, BY COUNTRY, 2018 (%)
  128. EUROPE: ANIMAL MODEL MARKET SHARE, BY REGION, 2018 (%)
  129. WESTERN EUROPE: ANIMAL MODEL MARKET SHARE, BY COUNTRY, 2018 (%)
  130. ASIA-PACIFIC: ANIMAL MODEL MARKET SHARE, BY COUNTRY, 2018 (%)
  131. MIDDLE EAST & AFRICA: ANIMAL MODEL MARKET SHARE, BY COUNTRY, 2018 (%)
  132. GLOBAL ANIMAL MODEL MARKET: COMPANY SHARE ANALYSIS, 2018 (%)
  133. JANVIER LABS: KEY FINANCIALS
  134. JANVIER LABS: SEGMENTAL REVENUE
  135. JANVIER LABS: REGIONAL REVENUE
  136. CHARLES RIVER LABORATORIES: KEY FINANCIALS
  137. CHARLES RIVER LABORATORIES.: SEGMENTAL REVENUE
  138. CHARLES RIVER LABORATORIES: REGIONAL REVENUE
  139. GENOWAY S.A.: KEY FINANCIALS
  140. GENOWAY S.A.: SEGMENTAL REVENUE
  141. GENOWAY S.A.: REGIONAL REVENUE
  142. ENVIGO: KEY FINANCIALS
  143. ENVIGO: SEGMENTAL REVENUE
  144. ENVIGO: REGIONAL REVENUE
  145. TACONIC LABORATORIES: KEY FINANCIALS
  146. TACONIC LABORATORIES: SEGMENTAL REVENUE
  147. TACONIC LABORATORIES: REGIONAL REVENUE
  148. TRANSGENIC, INC.: KEY FINANCIALS
  149. TRANSGENIC, INC.: SEGMENTAL REVENUE
  150. TRANSGENIC, INC.: REGIONAL REVENUE
  151. SAGE LABS: KEY FINANCIALS
  152. SAGE LABS: SEGMENTAL REVENUE
  153. SAGE LABS: REGIONAL REVENUE
  154. HORIZON DISCOVERY: KEY FINANCIALS
  155. HORIZON DISCOVERY: SEGMENTAL REVENUE
  156. HORIZON DISCOVERY: REGIONAL REVENUE
  157. CROWN BIOSCIENCE INC.: KEY FINANCIALS
  158. CROWN BIOSCIENCE INC.: SEGMENTAL REVENUE
  159. CROWN BIOSCIENCE INC.: REGIONAL REVENUE
  160. HARBOUR ANTIBODIES BV (A SUBSIDIARY OF HARBOUR BIOMED).: KEY FINANCIALS
  161. HARBOUR ANTIBODIES BV (A SUBSIDIARY OF HARBOUR BIOMED).: SEGMENTAL REVENUE
  162. HARBOUR ANTIBODIES BV (A SUBSIDIARY OF HARBOUR BIOMED).: REGIONAL REVENUE

Market Segmentation

Animal Model Animal Type Outlook (USD Billion, 2018-2030)

Pigs

Cats

Mice

Animal Model Technology Outlook (USD Billion, 2018-2030)

CRISPR

Microinjection

Embryonic Stem Cell Injection

Animal Model Application Outlook (USD Billion, 2018-2030)

Research and Development

Production

Quality Control

Animal Model End User Outlook (USD Billion, 2018-2030)

Research Institutes

Educational Institutes

Pharmaceutical Companies

Contract Research Organizations

Animal Model Regional Outlook (USD Billion, 2018-2030)

North America Outlook (USD Billion, 2018-2030)

North America Animal Model by Animal Type

Pigs

Cats

Mice

North America Animal Model by Technology

CRISPR

Microinjection

Embryonic Stem Cell Injection

North America Animal Model by Application

Research and Development

Production

Quality Control

North America Animal Model by End User

Research Institutes

Educational Institutes

Pharmaceutical Companies

Contract Research Organizations

US Outlook (USD Billion, 2018-2030)

US Animal Model by Animal Type

Pigs

Cats

Mice

US Animal Model by Technology

CRISPR

Microinjection

Embryonic Stem Cell Injection

US Animal Model by Application

Research and Development

Production

Quality Control

US Animal Model by End User

Research Institutes

Educational Institutes

Pharmaceutical Companies

Contract Research Organizations

CANADA Outlook (USD Billion, 2018-2030)

CANADA Animal Model by Animal Type

Pigs

Cats

Mice

CANADA Animal Model by Technology

CRISPR

Microinjection

Embryonic Stem Cell Injection

CANADA Animal Model by Application

Research and Development

Production

Quality Control

CANADA Animal Model by End User

Research Institutes

Educational Institutes

Pharmaceutical Companies

Contract Research Organizations

Europe Outlook (USD Billion, 2018-2030)

Europe Animal Model by Animal Type

Pigs

Cats

Mice

Europe Animal Model by Technology

CRISPR

Microinjection

Embryonic Stem Cell Injection

Europe Animal Model by Application

Research and Development

Production

Quality Control

Europe Animal Model by End User

Research Institutes

Educational Institutes

Pharmaceutical Companies

Contract Research Organizations

Germany Outlook (USD Billion, 2018-2030)

Germany Animal Model by Animal Type

Pigs

Cats

Mice

Germany Animal Model by Technology

CRISPR

Microinjection

Embryonic Stem Cell Injection

Germany Animal Model by Application

Research and Development

Production

Quality Control

Germany Animal Model by End User

Research Institutes

Educational Institutes

Pharmaceutical Companies

Contract Research Organizations

France Outlook (USD Billion, 2018-2030)

France Animal Model by Animal Type

Pigs

Cats

Mice

France Animal Model by Technology

CRISPR

Microinjection

Embryonic Stem Cell Injection

France Animal Model by Application

Research and Development

Production

Quality Control

France Animal Model by End User

Research Institutes

Educational Institutes

Pharmaceutical Companies

Contract Research Organizations

UK Outlook (USD Billion, 2018-2030)

UK Animal Model by Animal Type

Pigs

Cats

Mice

UK Animal Model by Technology

CRISPR

Microinjection

Embryonic Stem Cell Injection

UK Animal Model by Application

Research and Development

Production

Quality Control

UK Animal Model by End User

Research Institutes

Educational Institutes

Pharmaceutical Companies

Contract Research Organizations

ITALY Outlook (USD Billion, 2018-2030)

ITALY Animal Model by Animal Type

Pigs

Cats

Mice

ITALY Animal Model by Technology

CRISPR

Microinjection

Embryonic Stem Cell Injection

ITALY Animal Model by Application

Research and Development

Production

Quality Control

ITALY Animal Model by End User

Research Institutes

Educational Institutes

Pharmaceutical Companies

Contract Research Organizations

SPAIN Outlook (USD Billion, 2018-2030)

Spain Animal Model by Animal Type

Pigs

Cats

Mice

Spain Animal Model by Technology

CRISPR

Microinjection

Embryonic Stem Cell Injection

Spain Animal Model by Application

Research and Development

Production

Quality Control

Spain Animal Model by End User

Research Institutes

Educational Institutes

Pharmaceutical Companies

Contract Research Organizations

Rest Of Europe Outlook (USD Billion, 2018-2030)

Rest Of Europe Animal Model by Animal Type

Pigs

Cats

Mice

REST OF EUROPE Animal Model by Technology

CRISPR

Microinjection

Embryonic Stem Cell Injection

REST OF EUROPE Animal Model by Application

Research and Development

Production

Quality Control

REST OF EUROPE Animal Model by End User

Research Institutes

Educational Institutes

Pharmaceutical Companies

Contract Research Organizations

Asia-Pacific Outlook (USD Billion, 2018-2030)

Asia-Pacific Animal Model by Animal Type

Pigs

Cats

Mice

Asia-Pacific Animal Model by Technology

CRISPR

Microinjection

Embryonic Stem Cell Injection

Asia-Pacific Animal Model by Application

Research and Development

Production

Quality Control

Asia-Pacific Animal Model by End User

Research Institutes

Educational Institutes

Pharmaceutical Companies

Contract Research Organizations

China Outlook (USD Billion, 2018-2030)

China Animal Model by Animal Type

Pigs

Cats

Mice

China Animal Model by Technology

CRISPR

Microinjection

Embryonic Stem Cell Injection

China Animal Model by Application

Research and Development

Production

Quality Control

China Animal Model by End User

Research Institutes

Educational Institutes

Pharmaceutical Companies

Contract Research Organizations

Japan Outlook (USD Billion, 2018-2030)

Japan Animal Model by Animal Type

Pigs

Cats

Mice

Japan Animal Model by Technology

CRISPR

Microinjection

Embryonic Stem Cell Injection

Japan Animal Model by Application

Research and Development

Production

Quality Control

Japan Animal Model by End User

Research Institutes

Educational Institutes

Pharmaceutical Companies

Contract Research Organizations

India Outlook (USD Billion, 2018-2030)

India Animal Model by Animal Type

Pigs

Cats

Mice

India Animal Model by Technology

CRISPR

Microinjection

Embryonic Stem Cell Injection

India Animal Model by Application

Research and Development

Production

Quality Control

India Animal Model by End User

Research Institutes

Educational Institutes

Pharmaceutical Companies

Contract Research Organizations

Australia Outlook (USD Billion, 2018-2030)

Australia Animal Model by Animal Type

Pigs

Cats

Mice

Australia Animal Model by Technology

CRISPR

Microinjection

Embryonic Stem Cell Injection

Australia Animal Model by Application

Research and Development

Production

Quality Control

Australia Animal Model by End User

Research Institutes

Educational Institutes

Pharmaceutical Companies

Contract Research Organizations

Rest of Asia-Pacific Outlook (USD Billion, 2018-2030)

Rest of Asia-Pacific Animal Model by Animal Type

Pigs

Cats

Mice

Rest of Asia-Pacific Animal Model by Technology

CRISPR

Microinjection

Embryonic Stem Cell Injection

Rest of Asia-Pacific Animal Model by Application

Research and Development

Production

Quality Control

Rest of Asia-Pacific Animal Model by End User

Research Institutes

Educational Institutes

Pharmaceutical Companies

Contract Research Organizations

Rest of the World Outlook (USD Billion, 2018-2030)

Rest of the World Animal Model by Animal Type

Pigs

Cats

Mice

Rest of the World Animal Model by Technology

CRISPR

Microinjection

Embryonic Stem Cell Injection

Rest of the World Animal Model by Application

Research and Development

Production

Quality Control

Rest of the World Animal Model by End User

Research Institutes

Educational Institutes

Pharmaceutical Companies

Contract Research Organizations

Middle East Outlook (USD Billion, 2018-2030)

Middle East Animal Model by Animal Type

Pigs

Cats

Mice

Middle East Animal Model by Technology

CRISPR

Microinjection

Embryonic Stem Cell Injection

Middle East Animal Model by Application

Research and Development

Production

Quality Control

Middle East Animal Model by End User

Research Institutes

Educational Institutes

Pharmaceutical Companies

Contract Research Organizations

Africa Outlook (USD Billion, 2018-2030)

Africa Animal Model by Animal Type

Pigs

Cats

Mice

Africa Animal Model by Technology

CRISPR

Microinjection

Embryonic Stem Cell Injection

Africa Animal Model by Application

Research and Development

Production

Quality Control

Africa Animal Model by End User

Research Institutes

Educational Institutes

Pharmaceutical Companies

Contract Research Organizations

Latin America Outlook (USD Billion, 2018-2030)

Latin America Animal Model by Animal Type

Pigs

Cats

Mice

Latin America Animal Model by Technology

CRISPR

Microinjection

Embryonic Stem Cell Injection

Latin America Animal Model by Application

Research and Development

Production

Quality Control

Latin America Animal Model by End User

Research Institutes

Educational Institutes

Pharmaceutical Companies

Contract Research Organizations

Infographic

Free Sample Request

Kindly complete the form below to receive a free sample of this Report

Get Free Sample

Customer Strories

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization
Direct Access to Analyst
Deliverable Format
Platform Access
Discount on Next Purchase 10% 15% 15%
Printable Versions